LEARN MORE
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.
LEARN MOREEvents
CDKL5 Congress
Jefferies Global Healthcare Conference
JMP Securities Life Sciences Conference
Clinical Trials
Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.
Follow Us on Twitter
Dr. Masuoka from @MarinusPharma talking at AEDD meeting about CDKL5 and #rare #epilepsies #RareDiseases t.co/X7qQWNhrR8
Retweeted by Marinus Pharma
Show Media
